Literature DB >> 18689595

Clinical predictors and histologic appearance of acute exacerbations in chronic hypersensitivity pneumonitis.

Yasunari Miyazaki1, Tomoya Tateishi1, Takumi Akashi2, Yoshio Ohtani1, Naohiko Inase1, Yasuyuki Yoshizawa3.   

Abstract

BACKGROUND: Acute exacerbations (AEs) in idiopathic pulmonary fibrosis (IPF) are critical factors for its clinical course and prognosis. We have seen AEs and poor prognosis consequent to AE in patients with chronic hypersensitivity pneumonitis (HP), as has been seen in patients with IPF. The aim of this study was to evaluate the clinical features of the patients with AE in those with chronic HP.
METHODS: We reviewed 100 consecutive patients with chronic bird fancier lung (BFL) from 1993 to 2006, and analyzed the clinical characteristics, including history, and laboratory and immunologic, imaging, BAL, and histologic findings.
RESULTS: AE developed in 14 patients during this observation period (AE group), whereas 86 patients remained stable (non-AE [NAE] group). The 2-year frequency of AE among patients with chronic BFL having usual interstitial pneumonia (UIP)-like lesions seen on surgical lung specimens was 11.5%. Patients with AE were more likely to be smokers (p = 0.003). In pulmonary function test results, the mean total lung capacity (TLC) and diffusing capacity of the lung for carbon monoxide (Dlco) were lower in patients with AEs (TLC: AE patients, 63.0 +/- 16.8%; NAE patients, 81.6 +/- 20.0%; Dlco: AE patients, 41.9 +/- 19.0%; NAE patients, 60.0 +/- 19.4%). The mean number of lymphocytes in BAL fluid were lower (AE patients, 13.7 +/- 7.5 lymphocytes; NAE patients, 37.2 +/- 29.7 lymphocytes), while the number of neutrophils were greater in AE patients (AE patients, 10.7 +/- 17.6 neutrophils; NAE patients, 3.6 +/- 4.4 neutrophils). Histologic and/or radiologic findings revealed that all AE patients had UIP-like lesions. Diffuse alveolar damage was observed in six cases, whereas organizing pneumonia superimposed on preexistent fibrotic lesions was observed in two cases.
CONCLUSIONS: The present study showed several predictive factors for AE at the time of diagnosis. Low TLC and Dlco, low lymphocyte levels in BAL fluid, and a UIP-like pattern in histology at the time of diagnosis may be the risk factors for AE.

Entities:  

Mesh:

Year:  2008        PMID: 18689595     DOI: 10.1378/chest.08-0866

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  25 in total

Review 1.  Organizing pneumonia: a kaleidoscope of concepts and morphologies.

Authors:  Benjamin J Roberton; David M Hansell
Journal:  Eur Radiol       Date:  2011-07-10       Impact factor: 5.315

Review 2.  Bird fancier's lung: a state-of-the-art review.

Authors:  Andrew L Chan; Maya M Juarez; Kevin O Leslie; Heba A Ismail; Timothy E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2012-08       Impact factor: 8.667

Review 3.  Diagnosis and Treatment of Fibrotic Hypersensitivity Pneumonia. Where We Stand and Where We Need to Go.

Authors:  Margaret L Salisbury; Jeffrey L Myers; Elizabeth A Belloli; Ella A Kazerooni; Fernando J Martinez; Kevin R Flaherty
Journal:  Am J Respir Crit Care Med       Date:  2017-09-15       Impact factor: 21.405

4.  A sphingosine-1-phosphate receptor 1 agonist inhibits tertiary lymphoid tissue reactivation and hypersensitivity in the lung.

Authors:  C A Huppé; P Blais Lecours; A Lechasseur; D R Gendron; A M Lemay; E Y Bissonnette; M R Blanchet; C Duchaine; M C Morissette; H Rosen; D Marsolais
Journal:  Mucosal Immunol       Date:  2017-04-19       Impact factor: 7.313

Review 5.  Hypersensitivity pneumonitis.

Authors:  Ulrich Costabel; Yasunari Miyazaki; Annie Pardo; Dirk Koschel; Francesco Bonella; Paolo Spagnolo; Josune Guzman; Christopher J Ryerson; Moises Selman
Journal:  Nat Rev Dis Primers       Date:  2020-08-06       Impact factor: 52.329

6.  Clinical and molecular features of rapidly progressive chronic hypersensitivity pneumonitis.

Authors:  Yasushi Horimasu; Nobuhisa Ishikawa; Hiroshi Iwamoto; Shinichiro Ohshimo; Hironobu Hamada; Noboru Hattori; Morihito Okada; Koji Arihiro; Yuji Ohtsuki; Nobuoki Kohno
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

7.  An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.

Authors:  William D Travis; Ulrich Costabel; David M Hansell; Talmadge E King; David A Lynch; Andrew G Nicholson; Christopher J Ryerson; Jay H Ryu; Moisés Selman; Athol U Wells; Jurgen Behr; Demosthenes Bouros; Kevin K Brown; Thomas V Colby; Harold R Collard; Carlos Robalo Cordeiro; Vincent Cottin; Bruno Crestani; Marjolein Drent; Rosalind F Dudden; Jim Egan; Kevin Flaherty; Cory Hogaboam; Yoshikazu Inoue; Takeshi Johkoh; Dong Soon Kim; Masanori Kitaichi; James Loyd; Fernando J Martinez; Jeffrey Myers; Shandra Protzko; Ganesh Raghu; Luca Richeldi; Nicola Sverzellati; Jeffrey Swigris; Dominique Valeyre
Journal:  Am J Respir Crit Care Med       Date:  2013-09-15       Impact factor: 21.405

Review 8.  Imaging of Hypersensitivity Pneumonitis.

Authors:  Andrea L Magee; Steven M Montner; Aliya Husain; Ayodeji Adegunsoye; Rekha Vij; Jonathan H Chung
Journal:  Radiol Clin North Am       Date:  2016-08-11       Impact factor: 2.303

9.  Acute exacerbation of fibrotic hypersensitivity pneumonitis: incidence and outcomes.

Authors:  Jieun Kang; Yeon Joo Kim; Jooae Choe; Eun Jin Chae; Jin Woo Song
Journal:  Respir Res       Date:  2021-05-20

10.  Management of hypersensivity pneumonitis.

Authors:  Ioana O Agache; Liliana Rogozea
Journal:  Clin Transl Allergy       Date:  2013-02-04       Impact factor: 5.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.